The Lymphoma Channel on VJHemOnc is supported by Takeda and Johnson & Johnson Company. These supporters have no influence over the production of the content.
1:53
The current immunotherapeutic landscape for treatment of DLBCL
Christopher Melani
• 11 Dec 2023
2:15
ViPOR: a multi-targeted therapy for the treatment of R/R DLBCL
Christopher Melani
• 11 Dec 2023